Search by Drug Name or NDC
NDC 00682-0475-16 MAR-COF CG 7.5; 225 mg/5mL; mg/5mL Details
MAR-COF CG 7.5; 225 mg/5mL; mg/5mL
MAR-COF CG is a ORAL SYRUP in the HUMAN OTC DRUG category. It is labeled and distributed by Marnel Pharmaceuticals, LLC. The primary component is CODEINE PHOSPHATE; GUAIFENESIN.
MedlinePlus Drug Summary
Codeine is used to relieve mild to moderate pain. It is also used, usually in combination with other medications, to reduce coughing. Codeine will help relieve symptoms but will not treat the cause of symptoms or speed recovery. Codeine belongs to a class of medications called opiate (narcotic) analgesics and to a class of medications called antitussives. When codeine is used to treat pain, it works by changing the way the brain and nervous system respond to pain. When codeine is used to reduce coughing, it works by decreasing the activity in the part of the brain that causes coughing. Codeine is also available in combination with acetaminophen (Capital and Codeine, Tylenol with Codeine), aspirin, carisoprodol, and promethazine and as an ingredient in many cough and cold medications. This monograph only includes information about the use of codeine. If you are taking a codeine combination product, be sure to read information about all the ingredients in the product you are taking and ask your doctor or pharmacist for more information.
Related Packages: 00682-0475-16Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Codeine
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 00682-0475-16Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Guaifenesin
Product Information
| NDC | 00682-0475 |
|---|---|
| Product ID | 0682-0475_eb407f0f-29c5-41c5-e053-2995a90af95a |
| Associated GPIs | 43997002280947 |
| GCN Sequence Number | 064654 |
| GCN Sequence Number Description | codeine phosphate/guaifenesin LIQUID 7.5-225/5 ORAL |
| HIC3 | B4S |
| HIC3 Description | OPIOID ANTITUSSIVE-EXPECTORANT COMBINATION |
| GCN | 16017 |
| HICL Sequence Number | 000206 |
| HICL Sequence Number Description | CODEINE PHOSPHATE/GUAIFENESIN |
| Brand/Generic | Brand |
| Proprietary Name | MAR-COF CG |
| Proprietary Name Suffix | Expectorant |
| Non-Proprietary Name | CODEINE PHOSPHATE and GUAIFENESIN |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SYRUP |
| Route | ORAL |
| Active Ingredient Strength | 7.5; 225 |
| Active Ingredient Units | mg/5mL; mg/5mL |
| Substance Name | CODEINE PHOSPHATE; GUAIFENESIN |
| Labeler Name | Marnel Pharmaceuticals, LLC |
| Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC] |
| DEA Schedule | CV |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | 2023-12-31 |
Package
Package Images
NDC 00682-0475-16 (00682047516)
| NDC Package Code | 0682-0475-16 |
|---|---|
| Billing NDC | 00682047516 |
| Package | 473 mL in 1 BOTTLE (0682-0475-16) |
| Marketing Start Date | 2008-12-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 60a41229-b125-43d8-b2b4-0bf40feed764 Details
SPL UNCLASSIFIED SECTION
Uses
Warnings
Ask your doctor before use if
- you have a persistent cough, this may be a sign of a serious condition
- you have a persistent cough such as occurs with smoking, asthma, chronic bronchitis or emphysema
- you have a cough that is accompanied by excessive phlegm (mucus)
- you have chronic pulmonary disease or shortness of breath
- giving to a child who is taking other drugs
When using this product
- giving a higher dose than recommended by a doctor could result in serious side effects for your child. A special measuring device should be used to give an accurate dose of this product to children under 6 years of age
- may cause or aggravate constipation
Directions
Other information
Inactive ingredients
PRINCIPAL DISPLAY PANEL - 473 mL Bottle Label
MARNEL
NDC 0682-0475-16
MAR-COF
®CG
EXPECTORANT
ANTITUSSIVE
(cough suppressant)
EXPECTORANT
Each 5mL (one teaspoonful) for oral
administration contains:
Codeine Phosphate 7.5 mg
Guaifenesin 225 mg
Alcohol-Free / Sugar-Free
TAMPER EVIDENT:
Do not use if imprinted safety seal
under cap is broken or missing.
16 fl. oz. (473 mL)
INGREDIENTS AND APPEARANCE
| MAR-COF CG
EXPECTORANT
codeine phosphate and guaifenesin syrup |
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
| Labeler - Marnel Pharmaceuticals, LLC (080161449) |
| Registrant - Allegis Pharmaceuticals, LLC (792272861) |